Adoptive Therapy Using Antigen-Specific CD4 T-Cells

NCT02210104 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Issues with tetramer staining

Conditions

Melanoma
Sarcoma

Interventions

DRUG: Ipilimumab
DRUG: Cyclophosphamide
BIOLOGICAL: CD4+ T cells

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]